Symptomatic and functional outcomes after treatment with paliperidone palmitate 3-month formulation for 52 weeks in patients with clinically stable schizophrenia

Creative Commons License

Garcia-Portilla M. P., Llorca P., Maina G., Bozikas V. P., Devrimci-Ozguven H., Kim S., ...Daha Fazla

THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, cilt.10, 2020 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 10
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1177/2045125320926347
  • Dergi Adı: THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), EMBASE, Directory of Open Access Journals
  • Anahtar Kelimeler: functional remission, paliperidone palmitate 3-monthly formulation, paliperidone palmitate 1-monthly formulation, schizophrenia, symptomatic remission, QUALITY-OF-LIFE, ANTIPSYCHOTIC MEDICATION, MAINTENANCE TREATMENT, NATIONWIDE COHORT, NEGATIVE SYNDROME, REMISSION, RISPERIDONE, CARE, DISCONTINUATION, PREDICTORS
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Ankara Üniversitesi Adresli: Evet

Özet

Background: